EHMT2 and glioblastoma: When LN-229 and U-87 MG cells were treated by specific inhibitor of G9a or G9a expression in LN-229 and U-87 MG cells was knocked down by shG9a, these glioblastoma cells migrated much slower than control cells (Figures 2A–D).